Esquire Financial (ESQ) director adds 753 restricted shares in stock grant

Rhea-AI Filing Summary

Esquire Financial Holdings reported an insider stock grant and updated holdings. On December 10, 2025, a director acquired 753 shares of Esquire common stock at a reported price of $0, reflecting a restricted stock award. After this transaction, the director beneficially owns 142,679 shares directly and 2,500 shares in each of two insurance trusts held indirectly. The newly granted restricted shares vest 100% on December 10, 2026, and the reported holdings also include earlier restricted stock awards that vest in three equal annual installments beginning on dates ranging from December 19, 2023 through December 15, 2027.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mitzman Robert

(Last) (First) (Middle)

100 JERICHO QUADRANGLE

SUITE 100

(Street)

JERICHO NY 11753

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Esquire Financial Holdings, Inc. [ ESQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/10/2025		A		753(1)	A	$0	142,679(2)(3)(4)(5)(6)(7)	D
Common Stock								2,500	I	By insurance trust I
Common Stock								2,500	I	By insurance trust II

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares of restricted stock vest 100% on December 10, 2026.

2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2023.

3. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.

4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.

5. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.

6. Includes shares of restricted stock which vest in three equal annual installments commencing on December 3, 2027.

7. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.

	/s/ Eric S. Bader, pursuant to power of attorney	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Esquire Financial Holdings (ESQ) report in this filing?

A director of Esquire Financial Holdings, Inc. acquired 753 shares of common stock on December 10, 2025 at a reported price of $0, indicating a grant of restricted stock.

How many Esquire Financial Holdings (ESQ) shares does the director own after the transaction?

Following the reported transaction, the director beneficially owns 142,679 shares of Esquire common stock directly and 2,500 shares in each of two insurance trusts held indirectly.

When do the newly granted restricted shares of Esquire Financial Holdings vest?

The filing states that the 753 shares of restricted stock granted on December 10, 2025 vest 100% on December 10, 2026.

What other restricted stock awards are included in the director's Esquire Financial Holdings holdings?

The reported beneficial ownership includes restricted stock that vests in three equal annual installments commencing on December 19, 2023, December 16, 2024, December 9, 2025, December 19, 2026, December 3, 2027, and December 15, 2027.

Is this Esquire Financial Holdings insider filing for one person or multiple reporting persons?

The form is marked as "Form filed by One Reporting Person", indicating it relates to a single insider.

What is the reported relationship of the insider to Esquire Financial Holdings (ESQ)?

The reporting person is identified as a Director of Esquire Financial Holdings, Inc.